2016. WFH World Congress – Health-Related Quality of Life in Young Children with Haemophilia B treated with the novel long-acting nonacog beta pegol recombinant Factor IX

Kearney S, Santagostino E, Oyesiku L, Young N, Colberg T, Hoxer CS, Meunier J, Zhang C, Blanchette VS. Health-Related Quality of Life in Young Children with Haemophilia B treated with the novel long-acting nonacog beta pegol recombinant Factor IX. Haemophilia. 2016;22(Suppl. 4):119. Presented at: WFH 2016 World Congress; July 24-28, 2016; Orlando, FL, USA.